These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6123570)
1. Neurochemical effects of buspirone, a novel psychotropic drug, on the central cholinergic system. Kolasa K; Fusi R; Garattini S; Consolo S; Ladinsky H J Pharm Pharmacol; 1982 May; 34(5):314-7. PubMed ID: 6123570 [TBL] [Abstract][Full Text] [Related]
2. Mode of action of tiaspirone on the central cholinergic system. Kolasa K; Palazzi E; Salmoiraghi P; Guiso G; Caccia S; Garattini S; Consolo S Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):259-64. PubMed ID: 2572973 [TBL] [Abstract][Full Text] [Related]
3. Notes on buspirone's mechanisms of action. Garattini S; Caccia S; Mennini T J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069 [TBL] [Abstract][Full Text] [Related]
4. Decrease in rat striatal acetylcholine levels by some direct- and indirect-acting dopaminergic antagonists. Consolo S; Ladinsky H; Bianchi S Eur J Pharmacol; 1975; 33(2):345-51. PubMed ID: 1183479 [TBL] [Abstract][Full Text] [Related]
5. Neurochemical effects of minaprine, a novel psychotropic drug, on the central cholinergic system of the rat. Garattini S; Forloni GL; Tirelli S; Ladinsky H; Consolo S Psychopharmacology (Berl); 1984; 82(3):210-4. PubMed ID: 6425901 [TBL] [Abstract][Full Text] [Related]
6. Dopaminergic effects of buspirone, a novel anxiolytic agent. Cimino M; Ponzio F; Achilli G; Vantini G; Perego C; Algeri S; Garattini S Biochem Pharmacol; 1983 Mar; 32(6):1069-74. PubMed ID: 6838654 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics. Ladinsky H; Consolo S; Samanin R; Algeri S; Ponzio F Adv Biochem Psychopharmacol; 1980; 24():259-65. PubMed ID: 7405665 [No Abstract] [Full Text] [Related]
8. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens. Compton DR; Johnson KM J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468 [TBL] [Abstract][Full Text] [Related]
9. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone. Protais P; Lesourd M; Comoy E Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353 [TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat. Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370 [TBL] [Abstract][Full Text] [Related]
11. Neurochemical effects of buspirone in rat hippocampus: evidence for selective activation of 5HT neurons. Mennini T; Gobbi M; Ponzio F; Garattini S Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):40-9. PubMed ID: 2421657 [TBL] [Abstract][Full Text] [Related]
12. Effects of haloperidol and low dose clozapine on the acetylcholine turnover rate in rat forebrain structures. Bluth R; Langnickel R Biomed Biochim Acta; 1985; 44(10):1531-9. PubMed ID: 4084256 [TBL] [Abstract][Full Text] [Related]
13. Selective effects of buspirone and molindone on dopamine metabolism and function in the striatum and frontal cortex of the rat. McMillen BA; McDonald CC Neuropharmacology; 1983 Mar; 22(3):273-8. PubMed ID: 6133232 [TBL] [Abstract][Full Text] [Related]
14. Influence of noncholinergic drugs on rat striatal acetylcholine levels. McGeer PL; Grewaal DS; McGeer EG Brain Res; 1974 Nov; 80(2):211-7. PubMed ID: 4154064 [No Abstract] [Full Text] [Related]
15. Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission. McMillen BA J Neural Transm; 1985; 64(1):1-12. PubMed ID: 2866230 [TBL] [Abstract][Full Text] [Related]
16. Effect of dimethylamino-2-ethoxyimino-2-adamantane (CM 54903), a non-polar dimethylaminoethanol analog, on brain regional cholinergic neurochemical parameters. Vezzani A; Zatta A; Ladinsky H; Caccia S; Garattini S; Consolo S Biochem Pharmacol; 1982 May; 31(9):1693-8. PubMed ID: 7104032 [TBL] [Abstract][Full Text] [Related]
17. Buspirone: a potential atypical neuroleptic. Wood PL; Nair NP; Lal S; Etienne P Life Sci; 1983 Jul; 33(3):269-73. PubMed ID: 6135133 [TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Wilmot CA; Szczepanik AM Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063 [TBL] [Abstract][Full Text] [Related]
19. Presynaptic control of dopamine metabolism in the nucleus accumbens. Lack of effect of buspirone as demonstrated using in vivo voltammetry. Louilot A; Le Moal M; Simon H Life Sci; 1987 May; 40(20):2017-24. PubMed ID: 3573992 [TBL] [Abstract][Full Text] [Related]
20. Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine. Rupniak NM; Briggs RS; Petersen MM; Mann S; Reavill C; Jenner P; Marsden CD Clin Neuropharmacol; 1986; 9(3):282-92. PubMed ID: 3719573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]